Guardian Pharmacy Services Inc Revenue Growth Rates (GRDN), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Guardian Pharmacy Services Inc   (NYSE: GRDN)
 

GRDN's Revenue Growth by Quarter and Year

Guardian Pharmacy Services Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/GRDN/growth
https://api.csimarket.com/api/v1/companies/GRDN/fundamentals
https://api.csimarket.com/api/v1/companies/GRDN/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
GRDN Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 371.07
2nd Quarter June 351.77
1st Quarter March 336.60
FY 1,059.44





GRDN Revenue third quarter 2026 Y/Y Growth Comment
Guardian Pharmacy Services Inc reported decrease in Revenue in the third quarter 2026 by -1.69% to $ 371.07 millions, from the same quarter in 2025.
The decrease in the third quarter 2026 Guardian Pharmacy Services Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 15.59%.

Looking into third quarter 2026 results within Pharmacy Services & Retail Drugstore industry 5 other companies have achieved higher Revenue growth. While Guardian Pharmacy Services Inc ' s Revenue decline of -1.69% ranks overall at the positon no. 2077 in the third quarter 2026.


GRDN Revenue ( Y/Y Growth %) 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -1.69 %
2nd Quarter June 2.16 %
1st Quarter March 2.21 %
FY   -

Financial Statements
Guardian Pharmacy Services Inc 's third quarter 2026 Revenue $ 371.07 millions GRDN's Income Statement
Guardian Pharmacy Services Inc 's third quarter 2025 Revenue $ 377.43 millions Quarterly GRDN's Income Statement


GRDN Revenue (Quarter on Quarter Growth %)

 2026
 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September 5.49 %
2nd Quarter June 4.51 %
1st Quarter March -15.35 %
FY (Year on Year)   -


Back to GRDN Growth rate Comparisons >> Back to GRDN Growth rate Comparisons >>


Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #75
Overall #2077

Revenue Y/Y Growth Statistics
High Average Low
20.57 % 15.59 % 10.31 %
(Sep 30 2025)   (Jun 30 2026)
Revenue third quarter 2026 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #6
Retail Sector #75
Overall #2077
Revenue Y/Y Growth Statistics
High Average Low
20.57 % 15.59 % 10.31 %
(Sep 30 2025)   (Jun 30 2026)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Guardian Pharmacy Services Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
9.61 % 3.04 % -15.35 %
(Sep 30 2025)  


GRDN's III. Quarter Q/Q Revenue Comment
Guardian Pharmacy Services Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 5.49%, to $ 371.07 millions, from $351.77 millions in the second quarter.

Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Revenue growth. While Guardian Pharmacy Services Inc 's Revenue growth quarter on quarter, overall rank is 1188.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #2
Retail Sector #37
Overall #1188
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #2
Retail Sector #37
Overall #1188
Revenue Q/Q Growth Statistics
High Average Low
9.61 % 3.04 % -15.35 %
(Sep 30 2025)  


GRDN's III. Quarter Q/Q Revenue Comment
Guardian Pharmacy Services Inc achieved in the III. Quarter 2026 above company average sequential Revenue increase of 5.49%, to $ 371.07 millions, from $351.77 millions in the second quarter.

Within Pharmacy Services & Retail Drugstore industry only one company achieved higher sequential Revenue growth. While Guardian Pharmacy Services Inc 's Revenue growth quarter on quarter, overall rank is 1188.


Guardian Pharmacy Services Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending (Mar 31 2026) 12 Months Ending (Dec 31 2025) 12 Months Ending (Sep 30 2025) 12 Months Ending (Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 1,463.41
Y / Y Revenue Growth (TTM) 10.31 %
Year on Year Revenue Growth Overall Ranking # 830
Seqeuential Revenue Change (TTM) 0.51 %
Seq. Revenue Growth (TTM) Overall Ranking # 2077


Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Guardian Pharmacy Services Inc 's cumulative twelve months Revenue were $ 1,463 millions, company would post below average annual Revenue growth of 0.51% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Guardian Pharmacy Services Inc 's Revenue growth from the 351.77% growth in Mar 31 2026.

Among companies within the Retail sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 209 to 830.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 6
Retail Sector # 12
Overall # 830

Revenue TTM Y/Y Growth Statistics
High Average Low
20.57 %
 15.59 %
10.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 75
S&P 500 # 2077
Cumulative Revenue growth Comment
With the quarterly Revenue reported in the Jun 30 2026 period, Guardian Pharmacy Services Inc 's cumulative twelve months Revenue were $ 1,463 millions, company would post below average annual Revenue growth of 10.31% year on year, if the fiscal year would end at Jun 30 2026.
A slow-down in the Guardian Pharmacy Services Inc 's Revenue growth from the 351.77% growth in Mar 31 2026.

Among companies within the Retail sector 11 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 209 to 830.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 6
Retail Sector # 12
Overall # 830

Revenue TTM Y/Y Growth Statistics
High Average Low
20.57 %
15.59 %
10.31 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 6
Sector # 75
S&P 500 # 2077




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
GRDN's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Sep 30 2026 within Retail SectorY/Y Change %Revenue for the quarter ending Sep 30 2026
Albertsons Companies Inc -0.11%$ -0.110 millions
Autonation Inc -0.39%$ -0.385 millions
Grabagun Digital Holdings Inc -0.70%$ -0.702 millions
Guardian Pharmacy Services Inc -1.68%$ -1.684 millions
Builders Firstsource Inc -2.19%$ -2.194 millions
Hour Loop Inc -3.32%$ -3.316 millions
Growgeneration Corp -4.42%$ -4.424 millions
Group 1 Automotive Inc-6.68%$ -6.675 millions
Asbury Automotive Group Inc -8.07%$ -8.067 millions
The Honest Company Inc -8.52%$ -8.516 millions
Camping World Holdings Inc -12.36%$ -12.358 millions
Nu Skin Enterprises Inc -14.49%$ -14.493 millions
Grove Collaborative Holdings Inc -15.81%$ -15.807 millions
Petmed Express Inc -17.61%$ -17.609 millions
Bark Inc -18.13%$ -18.135 millions
Latch Inc -18.86%$ -18.857 millions
1 800 Flowers Com Inc-20.21%$ -20.214 millions
The Beachbody Company Inc -24.25%$ -24.249 millions
Monro Inc -40.25%$ -40.251 millions
Weis Markets inc-41.22%$ -41.216 millions
Crown Equity Holdings Inc -63.44%$ -63.441 millions
Hwh International Inc -64.87%$ -64.868 millions
Stemtech Corporation-66.86%$ -66.856 millions
Vroom Inc -96.18%$ -96.179 millions


About Guardian Pharmacy Services Inc Revenue Growth Rates (GRDN), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Guardian Pharmacy Services Inc (CIK 1802255).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001628280-26-071056
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Guardian Pharmacy Services Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.